Literature DB >> 9199426

Extracellular proteins of Cryptococcus neoformans and host antibody response.

L C Chen1, L A Pirofski, A Casadevall.   

Abstract

Proteins secreted by the fungal pathogen Cryptococcus neoformans may be involved in invasion and could be useful in vaccine design. Despite the medical importance of this fungus, little is known about its extracellular proteins or the immune response to these antigens. To study C. neoformans extracellular proteins, 12 strains were metabolically radiolabeled and protein supernatants were analyzed. Both strain- and growth condition-dependent differences were observed. Enzymatic assays of filtered culture supernatants revealed butyrate esterase and caprylate esterase lipase activity for 11 of 12 strains, as well as acid phosphatase, naphthol-AS-BI-phosphohydrolase, and beta-glucosidase activities in some strains. Serum from infected rodents immunoprecipitated several secreted proteins, consistent with in vivo expression and development of an antibody response. For strain 24067, two immunodominant species, of approximately 75 and 30 kDa, were recognized. The relative intensity of the autoradiographic bands depended on the route of infection for both rats and mice. In summary, our results indicate that (i) there are multiple proteins in C. neoformans culture supernatants, (ii) there are strain differences in supernatant protein profiles, (iii) there are differences in supernatant protein profile depending on the growth conditions, (iv) there are several new extracellular and/or cell-associated enzymatic activities, and (v) antibodies to several supernatant proteins are made in the course of infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199426      PMCID: PMC175368          DOI: 10.1128/iai.65.7.2599-2605.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.

Authors:  E Reiss; R Cherniak; R Eby; L Kaufman
Journal:  Diagn Immunol       Date:  1984

2.  Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans.

Authors:  S H Turner; R Cherniak; E Reiss
Journal:  Carbohydr Res       Date:  1984-02-15       Impact factor: 2.104

3.  Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection.

Authors:  M Feldmesser; A Casadevall
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

4.  Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat.

Authors:  D Goldman; S C Lee; A Casadevall
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

5.  Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans.

Authors:  B L Wickes; T D Moore; K J Kwon-Chung
Journal:  Microbiology       Date:  1994-03       Impact factor: 2.777

6.  Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City.

Authors:  B P Currie; L F Freundlich; A Casadevall
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

7.  Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

8.  Properties of an acid phosphatase from Legionella micdadei which blocks superoxide anion production by human neutrophils.

Authors:  A K Saha; J N Dowling; K L LaMarco; S Das; A T Remaley; N Olomu; M T Pope; R H Glew
Journal:  Arch Biochem Biophys       Date:  1985-11-15       Impact factor: 4.013

9.  Contribution to the study of the enzymatic profiles of yeast organisms with medical interest.

Authors:  M Casal; M J Linares
Journal:  Mycopathologia       Date:  1983-03-22       Impact factor: 2.574

10.  Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

Authors:  R A Fromtling; H J Shadomy; E S Jacobson
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574

View more
  17 in total

1.  Variants of a Cryptococcus neoformans strain elicit different inflammatory responses in mice.

Authors:  L C Chen; A Casadevall
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

2.  Purification and characterization of a 43-kilodalton extracellular serine proteinase from Cryptococcus neoformans.

Authors:  Jae il Yoo Ji; Yeong Seon Lee; Chul-Yong Song; Bong Su Kim
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  Utilization of fish meal and fish oil for production of Cryptococcus sp. MTCC 5455 lipase and hydrolysis of polyurethane thereof.

Authors:  K Thirunavukarasu; S Purushothaman; M K Gowthaman; T Nakajima-Kambe; C Rose; N R Kamini
Journal:  J Food Sci Technol       Date:  2015-01-04       Impact factor: 2.701

4.  Cryptococcus strains with different pathogenic potentials have diverse protein secretomes.

Authors:  Leona T Campbell; Anna R Simonin; Cuilan Chen; Jannatul Ferdous; Matthew P Padula; Elizabeth Harry; Markus Hofer; Iain L Campbell; Dee A Carter
Journal:  Eukaryot Cell       Date:  2015-04-03

5.  Antifungal susceptibility, enzymatic activity, PCR-fingerprinting and ITS sequencing of environmental Cryptococcus laurentii isolates from Uberaba, Minas Gerais, Brazil.

Authors:  Kennio Ferreira-Paim; Leonardo Andrade-Silva; Delio Jose Mora; Eliane Lages-Silva; André Luiz Pedrosa; Paulo Roberto da Silva; Anderson Assunção Andrade; Mario León Silva-Vergara
Journal:  Mycopathologia       Date:  2011-11-25       Impact factor: 2.574

6.  An opsonizing monoclonal antibody that recognizes a noncapsular epitope expressed on Cryptococcus neoformans.

Authors:  G J Merkel; B A Scofield
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Heat shock protein 70 (hsp70) as a major target of the antibody response in patients with pulmonary cryptococcosis.

Authors:  H Kakeya; H Udono; S Maesaki; E Sasaki; S Kawamura; M A Hossain; Y Yamamoto; T Sawai; M Fukuda; K Mitsutake; Y Miyazaki; K Tomono; T Tashiro; E Nakayama; S Kohno
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

8.  Do kinetics of the humoral response to Cryptococcus neoformans proteins during murine cryptococcosis reflect outcome?

Authors:  S Neuville; O Lortholary; F Dromer
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Therapeutic efficacy of a conjugate vaccine containing a peptide mimotope of cryptococcal capsular polysaccharide glucuronoxylomannan.

Authors:  Kausik Datta; Andrew Lees; Liise-anne Pirofski
Journal:  Clin Vaccine Immunol       Date:  2008-06-04

10.  The fatal fungal outbreak on Vancouver Island is characterized by enhanced intracellular parasitism driven by mitochondrial regulation.

Authors:  Hansong Ma; Ferry Hagen; Dov J Stekel; Simon A Johnston; Edward Sionov; Rama Falk; Itzhack Polacheck; Teun Boekhout; Robin C May
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.